A novel, orally effective hypoglycemic agent, SaRI 59–801, in laboratory animals
- 1 January 1985
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 6 (1) , 67-77
- https://doi.org/10.1002/ddr.430060109
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tubular Reabsorption Rates as Related to Elevated Glomerular Filtration in Diabetic ChildrenDiabetes, 1983
- Studies on the Pathophysiology of Diabetic Retinopathy: The Blood-Retinal Barrier in DiabetesDiabetes, 1983
- Diabetes and Atherosclerosis: an OverviewDiabetes, 1981
- Glomerular Filtration Rate and Extracellular Fluid Volumes during Normoglycemia and Moderate Hyperglycemia in DiabeticsScandinavian Journal of Clinical and Laboratory Investigation, 1973
- Sensory Perception Thresholds in Patients with Juvenile Diabetes and Their Close RelativesNew England Journal of Medicine, 1972
- Insulin and Oral Hypoglycaemic Agents1 IDrugs, 1972
- Insulin Levels in Primates by ImmunoassayScience, 1970
- Development of Tachyphylaxis to the Antilipolytic, Hypoglycemic Agent, 5-Methylpyrazole-3-carboxylic Acid, U-19425.Experimental Biology and Medicine, 1967
- Phenformin and lactic acidosisClinical Pharmacology & Therapeutics, 1966
- GENERAL PHARMACODYNAMICS OF THE HYPOGLYCEMIC ARYLSULFONAMIDESAnnals of the New York Academy of Sciences, 1959